Scholarlink

<p>HBV recurrence after liver transplantation (LT) can occur despite removal of the infected liver and antiviral prophylaxis. Timing and mechanisms of HBV and HDV recurrence remain unclear. We evaluated post-transplant viral kinetics to address this gap. Twelve HBV patients undergoing LT, including five with HDV-coinfection, were prospectively enrolled. Serial serum and liver samples were rigorously collected before, during, and post-LT to characterize viral kinetics. HBV-DNA, HDV-RNA, HBsAg, and HDAg were detected in all explanted livers, whereas cccDNA was found only in HBV-monoinfected patients. Serum HBV-DNA, detectable in five recipients before LT, became undetectable within hours from LT. In HBV-monoinfected patients, baseline HBsAg levels were low (&lt; 3logIU/mL) and cleared rapidly after LT, with faster disappearance in those receiving HBIG (5 days vs. 6 months). Among HDV-recipients, all treated with HBIG, HBsAg clearance was rapid when baseline HBsAg levels were &lt;3log<sub>10</sub>IU/mL (12&#xa0;h) and delayed at higher levels (6 months). HDV-RNA kinetics paralleled HBsAg decline. Post-transplant liver biopsies (reperfusion, 3- and 12-months) tested negative for viral markers, except for isolated intrahepatic HDV detection at 3-months in one patient. No intrahepatic HBV reinfection was observed post-LT. Occasional intrahepatic HDV detection supports the need for improved prophylactic strategies in HDV-recipients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Early hepatitis B and delta virus kinetics in patients undergoing liver transplantation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月21日

查看全文
  • Sara Battistella,
  • Anna Pocurull,
  • Thais Leonel,
  • Sergio Rodríguez-Tajes,
  • Yiliam Fundora,
  • Louis Shekhtman,
  • Leeor Hershkovich,
  • Scott J. Cotler,
  • Harel Dahari,
  • Tiffany Fortney,
  • Mark Anderson,
  • Gavin Cloherty,
  • Juan Carlos Hurtado,
  • Maria Saez-Palma,
  • Sabela Lens,
  • Sofía Pérez-del-Pulgar,
  • Xavier Forns

摘要

HBV recurrence after liver transplantation (LT) can occur despite removal of the infected liver and antiviral prophylaxis. Timing and mechanisms of HBV and HDV recurrence remain unclear. We evaluated post-transplant viral kinetics to address this gap. Twelve HBV patients undergoing LT, including five with HDV-coinfection, were prospectively enrolled. Serial serum and liver samples were rigorously collected before, during, and post-LT to characterize viral kinetics. HBV-DNA, HDV-RNA, HBsAg, and HDAg were detected in all explanted livers, whereas cccDNA was found only in HBV-monoinfected patients. Serum HBV-DNA, detectable in five recipients before LT, became undetectable within hours from LT. In HBV-monoinfected patients, baseline HBsAg levels were low (< 3logIU/mL) and cleared rapidly after LT, with faster disappearance in those receiving HBIG (5 days vs. 6 months). Among HDV-recipients, all treated with HBIG, HBsAg clearance was rapid when baseline HBsAg levels were <3log10IU/mL (12 h) and delayed at higher levels (6 months). HDV-RNA kinetics paralleled HBsAg decline. Post-transplant liver biopsies (reperfusion, 3- and 12-months) tested negative for viral markers, except for isolated intrahepatic HDV detection at 3-months in one patient. No intrahepatic HBV reinfection was observed post-LT. Occasional intrahepatic HDV detection supports the need for improved prophylactic strategies in HDV-recipients.